Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Adolescent Substance AbuseAttention Deficit Hyperactivity Disorder
Interventions
BEHAVIORAL

Medication integration protocol

MIP is a 5 session protocol. The first session consists of pretreatment assessment activities using measures administered during routine clinical intake. The following sessions, MIP Sessions 1-4, are meant to be delivered sequentially, commencing sometime after session 2 or 3 of treatment, that is, after completion of initial treatment contracting and engagement interventions that will usually be focused on ASU-related referral problems for this population. The proposed pilot work will shed light on the optimal timing for MIP Sessions 1-4.

Trial Locations (1)

10009

Roberto Clemente Center, New York

All Listed Sponsors
lead

The National Center on Addiction and Substance Abuse at Columbia University

OTHER

NCT01539941 - Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care | Biotech Hunter | Biotech Hunter